Robert John DelAversano

All filings by Robert John DelAversano on record concern Grace Therapeutics, Inc. Altogether 3 filings, all relating to 28 August 2026.

The filings describe grants, exercises and other transfers rather than trades on the open market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.

The newest entry dates from 1 September 2026: an option exercise, in Grace Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.